Ads
related to: Canada and Pfizer
Search results
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoSales of Enbrel, developed with Amgen, toppled 17% to $830 million. Pfizer sells Enbrel outside the...
Transatlantic Trade | US and Europe – Week of August 9, 2021
The National Law Review· 2 weeks agoThe US Government also moved forward with approving the Pfizer/BioNTech and Moderna vaccines for a booster dose for immunocompromised Americans only this ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 3 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
Srini Pillay M.D.
Psychology Today· 23 hours agoAfter receiving a Medical Research Council Scholarship to study the neurochemistry of panic, he completed his residency at McLean Hospital/Harvard...
Quebec class action authorized against 16 pharma companies for role in opioid crisis
CBC via Yahoo News· 1 week agoA class-action lawsuit has been authorized to proceed against 16 pharmaceutical companies for their...
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape· 2 weeks agoA study of more than 9000 family physicians in Ontario also found that the physicians with the...
3 Defensive Stocks to Protect Your Portfolio in 2024 | Investing.com Canada
Investing.com· 2 days agoUnderstandably, as the wider Iran-Israel conflict would lead to regional and global disruptions in...
Omicron may raise re-infection risk; booster protection documented
AOL· 2 weeks agoIn South Africa, where Omicron was first reported, researchers reviewed data on nearly 2.8 million...
Amazon Ads, Reddit and MTV are 2024 Digiday Content Marketing Award finalists
Digiday· 2 days agoThis year’s Digiday Content Marketing Awards finalists focused on creating more relatable, interactive campaigns to improve consumer engagement. These shortlist entries showcase the companies ...
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
Morningstar· 2 days agoXTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the ...